Cross Country Healthcare, Inc. (CCRN) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	1.0B	1.1B	1.3B	2.0B	2.8B
Cost of Revenue	803.1M	857.5M	1.1B	1.6B	2.2B
Gross Profit	198.8M	196.8M	274.3M	450.4M	624.5M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	147.1M	200.7M	254.8M	315.0M	324.2M
General & Admin Expense	—	—	246.3M	303.5M	—
Selling & Marketing Expense	—	—	8.5M	11.5M	—
Other Expenses	72.6M	(441.0K)	36.3M	22.7M	30.4M
Total Operating Expenses	219.7M	200.2M	291.1M	337.7M	354.6M
Cost and Expenses	1.0B	1.1B	1.4B	1.9B	2.5B
Operating Income (EBIT)	(20.9M)	(3.5M)	(16.9M)	112.7M	269.9M
Non-Operating
Interest Income	3.4M	3.1M	2.0M	—	10.0K
Interest Expense	2.2M	2.2M	2.2M	8.1M	14.4M
Net Interest Income	1.2M	913.0K	(138.0K)	(8.1M)	(14.4M)
Other Non-Op Income/Expense	(65.5M)	(80.0M)	467.0K	(9.8M)	(16.8M)
Non-Operating Income (excl Interest)	63.2M	77.8M	(16.1M)	1.7M	2.4M
EBT (Pre-Tax Income)	(86.3M)	(83.5M)	(16.4M)	102.9M	253.1M
Income Tax Expense	12.3M	11.3M	(1.8M)	30.3M	67.1M
Bottom Line
Net Income	(98.6M)	(94.9M)	(14.6M)	72.6M	186.0M
Earnings from Cont. Ops	(98.6M)	(94.9M)	(14.6M)	72.6M	186.0M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(98.6M)	(94.9M)	(14.6M)	72.6M	186.0M
Per Share
Basic EPS	($3.05)	($2.93)	($0.44)	$2.07	$5.09
Diluted EPS	($3.05)	($2.93)	($0.44)	$2.05	$5.02
Revenue Per Share	$31.84	$32.53	$40.26	$57.45	$75.74
Shares
Basic Shares Outstanding	31.5M	32.4M	33.4M	35.2M	37.0M
Diluted Shares Outstanding	31.5M	32.4M	33.4M	35.5M	37.5M
Profitability Metrics
EBITDA	(68.4M)	(64.5M)	16.8M	129.3M	280.1M
D&A	15.7M	16.8M	17.5M	18.3M	12.6M
EBIT	(84.1M)	(81.3M)	(725.0K)	111.0M	267.5M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026